Navigation Links
HealthLeaders-InterStudy Launches Pharmacy Benefit Evaluator
Date:6/15/2009

The New Pharmacy Benefit Evaluator Analyzes Health Plan Pharmacy Benefit Structure, Spending and the Plan-PBM Relationship to Inform Managed Care Sales Strategy Development

NASHVILLE, Tenn., June 15 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, has enhanced its Pharmacy Benefit Evaluator, a Web-based product that analyzes health plan pharmacy benefit structure and spending and the health plan-to-pharmacy benefit manager (PBM) relationship to better inform managed care sales strategy development. Now available with enrollment data as of January 2009, the new Pharmacy Benefit Evaluator platform offers an easy-to-navigate interface as well as a flexible report structure that enables comparisons across PBMs and health plans to evaluate how organizations compare on co-pays, spending and benefit design.

Pharmacy Benefit Evaluator delivers comprehensive data on managed care pharmacy purchasing including:

  • Health plan profiles that deliver overall medical and pharmacy lives and growth rates by national and regional health plan.
  • How plans controls access to drugs, with insight into tiers, co-pays and formulary management.
  • PBM profiles that detail key health plan affiliations with enrollment by benefit design type and state.

Pharmacy Benefit Evaluator is a vital tool for managed care sales teams as it provides clarity into the pharmacy benefit manager book of business.

"Our PBM research is conducted at the health plan level to provide the highest quality data available to differentiate between the lives where the PBM is making formulary decisions and where the PBM is providing administrative services," said Eric Matckie, vice president, strategy & analytics for HealthLeaders-InterStudy. "With a clear understanding of who's making formulary decisions in place, Pharmacy Benefit Evaluator becomes a powerful resource for pull-through activity, as sales and marketing teams can evaluate at the state-level how organizations compare on covered lives and benefit structure to uncover opportunities that will deliver the greatest return on investment."

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HealthLeaders-InterStudy Offers District Survival Kit to Arm Pharmaceutical Sales Teams With Local-Level Managed Care Market Intelligence
2. Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities
3. GE Launches Program to Doctors, Hospitals to Accelerate EMR Adoption; First $100 Million of healthymagination Commitment
4. Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers
5. Cancer Related Educational Video Sharing and Interactive Community Launches Online
6. Salient Mobility Launches the Text For a Cause(TM) Campaign in Raising Awareness Through Wireless Health Tips
7. Pacific Shore Holdings, Inc. Launches Burner Balm a Revolutionary, Energy-Boosting, Appetite-Suppressing, Fat-Burning Lip Balm - Natural, Green and Cost-Effective - Featured on NBCs Today Show
8. Oclaro Launches Eye-Safe High Power Laser Diodes at LASER 2009
9. Center on Media and Child Health Launches "Ask the Mediatrician"
10. ReStart DC Launches Life-Saving Public Access Defibrillation Program
11. Imaging Advantage Launches Operations at Mercy Health Partners Metro Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: